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In the last 30 years a revolution has occurred in the diagnosis and management of vascular anomalies. The great changes began with Mul-
liken and Glowacki separation of hemangiomas and vascular anomalies. Their work has now morphed into the ISSVA classification. Subse-
quently the discovery of the significance of the presence of GLUT-1 in the diagnosis of the hemangiomas of infancy gave us a new marker 
in our quest for accurate classification. Now genetic breakthroughs have led us into a “Star Wars” like environment in the experimental labo-
ratory. During all these events the critical role of the pathologist has become more evident. Understanding the histopathology of anomalies 
has greatly aided in our approach to therapies. Moreover, genetic findings do not have full significance without the morphologic framework
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Introduction
Histopathological examination of vascular anomalies 
and pathology represents a crucial moment in the di-
agnostic-therapeutic pathway in which the analysis of 
a sample becomes the confirmation or enrichment of 
information that the clinic and the instrumental exami-
nations have already outlined and, at the same time, 
the starting point to trace further therapy.
It also allows to verify the adequacy and representa-
tiveness of the sample for the genetic examination, 
fundamental both for prognostic purposes and for the 
possible pharmacological treatment in order to guar-
antee the best quality of life for patients.
The recommendations for an adequate histo-patho-
logical examination for vascular abnormalities also 
arise as a requirement to standardize the manage-
ment and anatomo-pathological reporting for this type 
of pathology and to complete the guidelines for the 
diagnostic/therapeutic management of the same, al-
ready drafted by SISAV in the 2015 with a multidis-
ciplinary approach, and in adherence to the ISSVA 
Classification for vascular abnormalities, which repre-
sents the current best international classification. 
Goals of correct histopathological 
examination by recommendations 
validated by a scientific society
I Define the exact nature of the lesion (diagnostic 
confirmations or ex novo diagnosis)
II Evaluate the exact tissue involved
III Verify the presence of proliferative foci in the lesion
IV Identify conditions of risk and complications
V Ensure the adequacy of the process (sampling, 
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preparation and staining) for second opinion and 
biomolecular investigations
VI Ensure the preservation of material for any further 
investigations and case studies
Operating instructions
1 What to send with samples:
a histopathological examination request (mini-
mum requirements);
b preoperative iconographic documentation;
c results of hematological analysis;
d diagnostic imaging (CT, CT-angiography, MRI, 
Ultrasound, Doppler-ultrasound…);
e report of previous treatments (embolisation, la-
ser, pharmacological therapy, surgery…);
f suitable material for further different investiga-
tions:
• not fixed;
- within one hour of sampling;
• formalin fixed;
- correlated by a sample in RNA later;
- cryopreservation in biobanks;
g blood sample in EDTA.
2 Fixation:
a in buffered formalin;
b minimum fixative volume 1:10;
c cooled buffered formalin for large samples.
3 Sampling:
a specimen orientation;
b macroscopic photographic documentation;
c possible “repere” in colored china;
d serial sections, oriented and numbered pro-
gressively. Every sample smaller than 10 cm of 













6 staining for reticuline;
7 Weigert elastic;
8 alkaline phosphatase or Alizarin Red for 


















 Sec. ISSVA Classification 2014 (Rev. 2018).
6 Histopathological diagnosis must report:
a vascular anomalies according to ISSVA Classi-
fication;
b identification of the recognised vascular anom-
alies according to SISAV guidelines:
• extension;
• involvement of anatomical structures;
• resection margins;
c presence of additional components associated 
with vascular injury;
d inflammatory state;
e presence of proliferative, vascular and ex-
travascular foci (i.e. “nidus”);




• location of the mutation:
- genetic;
- somatic;
• type of mutation;
• percentage of mutated gene.
8 Preservation of the material:
 despite having implemented the Guideline on 
“Traceability, collection, transport and storage 
of cells and tissues for diagnostic investigations”, 
published in May 2015 - SIAPEC, it is advisable 
to keep the residual material after sampling for at 
least 3 months after the scheduled date for dispos-
al.
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